HSK21542 clinical trials
How each study uses HSK21542 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the HSK21542 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- HSK21542 Injection
- 3
Studies by the year they started
7 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Haisco Pharmaceutical Group Co., Ltd. (5) · Sichuan Provincial People's Hospital (1) · Xizang Haisco Pharmaceutical Co., Ltd (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses HSK21542 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.Not yet recruitingPhase 2Xizang Haisco Pharmaceutical Co., LtdNCT06290375Written as HSK21542 tablet
- A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal ImpairmentRecruitingPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT05947097Written as HSK21542 Injection
- A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07442877Written as HSK21542 dose level 1
- Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis PatientsCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT06238388Written as HSK21542 Injection
- A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in PONVCompletedNot applicableSichuan Provincial People's HospitalNCT06170476Written as HSK21542-60μg
- Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.CompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT05835934Written as [14C]HSK21542
- A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain TreatmentCompletedPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT05390905Written as HSK21542 Injection